{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:41:05Z","timestamp":1793047265647,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-061093"],"award-info":[{"award-number":["AI-061093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-086037"],"award-info":[{"award-number":["AI-086037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-48693"],"award-info":[{"award-number":["AI-48693"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jaip.2021.07.044","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T11:56:06Z","timestamp":1627905366000},"page":"4095-4102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Clinical Manifestations and Outcomes of Activated Phosphoinositide 3-Kinase \u03b4 Syndrome from the USIDNET Cohort"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4054-2491","authenticated-orcid":false,"given":"Jessica","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Garabedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsay","family":"Fuleihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.07.044_bib1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jaip.2021.07.044_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2021.07.044_bib3","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3389\/fimmu.2018.02043","article-title":"The treatment of activated PI3Kdelta syndrome","volume":"9","author":"Coulter","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2021.07.044_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.07.044_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","article-title":"Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase delta syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase delta Syndrome Registry","volume":"9","author":"Maccari","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2021.07.044_bib6","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1073\/pnas.1617244114","article-title":"Conformational disruption of PI3Kdelta regulation by immunodeficiency mutations in PIK3CD and PIK3R1","volume":"114","author":"Dornan","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2021.07.044_bib7","doi-asserted-by":"crossref","first-page":"16996","DOI":"10.1073\/pnas.0908444106","article-title":"A\u00a0frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membrane","volume":"106","author":"Mandelker","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2021.07.044_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study","volume":"138","author":"Elkaim","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.07.044_bib9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fimmu.2018.00338","article-title":"Respiratory manifestations of the activated phosphoinositide 3-kinase delta syndrome","volume":"9","author":"Condliffe","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2021.07.044_bib10","first-page":"19","article-title":"Clinical and immunological analysis of patients with activated phosphoinositide 3-kinase delta syndrome resulting from PIK3CD mutation [in Chinese]","volume":"55","author":"Tang","year":"2017","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.jaip.2021.07.044_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fimmu.2018.00237","article-title":"Herpesviruses in the activated phosphatidylinositol-3-kinase-delta syndrome","volume":"9","author":"Cohen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2021.07.044_bib12","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.3390\/v5123192","article-title":"Make yourself at home: viral hijacking of the PI3K\/Akt signaling pathway","volume":"5","author":"Diehl","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.jaip.2021.07.044_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-12-396456-4.00002-X","article-title":"HijAkt: the PI3K\/Akt pathway in virus replication and pathogenesis","volume":"106","author":"Dunn","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.jaip.2021.07.044_bib14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.virol.2015.02.040","article-title":"The role of PI3K\/Akt in human herpesvirus infection: from the bench to the bedside","volume":"479-80","author":"Liu","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jaip.2021.07.044_bib15","doi-asserted-by":"crossref","first-page":"e869","DOI":"10.1371\/journal.pone.0000869","article-title":"Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase","volume":"2","author":"Eickholt","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2021.07.044_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10875-014-0012-9","article-title":"Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility","volume":"34","author":"Crank","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2021.07.044_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clim.2017.01.004","article-title":"Genetic defects in PI3Kdelta affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections","volume":"176","author":"Wentink","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2021.07.044_bib18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2018.00446","article-title":"Exhaustion of the CD8(+) T cell compartment in patients with mutations in phosphoinositide 3-kinase delta","volume":"9","author":"Wentink","year":"2018","journal-title":"Front Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821008850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821008850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:30:25Z","timestamp":1761975025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821008850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2213219821008850"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.07.044","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Manifestations and Outcomes of Activated Phosphoinositide 3-Kinase \u03b4 Syndrome from the USIDNET Cohort","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.07.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}